Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A detection panel of novel methylated DNA markers for malignant pleural effusion. | Front Oncol | 2022 | 36176402 | PubTator, text mining | PubMed |
| HOX genes in stem cells: Maintaining cellular identity and regulation of differentiation. | Front Cell Dev Biol | 2022 | 36176275 | PubTator, text mining | PubMed |
| Panobinostat (LBH589) increase survival in adult xenografic model of acute lymphoblastic leukemia with t(4;11) but promotes antagonistic effects in combination with MTX and 6MP. | Med Oncol | 2022 | 36175721 | PubTator, text mining | PubMed |
| Potential application of human SALL4 on oral squamous cell carcinoma. | Ann Transl Med | 2022 | 36172107 | PubTator, text mining | PubMed |
| TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma. | Nat Commun | 2022 | 36167829 | PubTator, text mining | PubMed |
| HOXA5 inhibits the proliferation of extrahepatic cholangiocarcinoma cells by enhancing MXD1 expression and activating the p53 pathway. | Cell Death Dis | 2022 | 36167790 | PubTator, text mining | PubMed |
| E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer. | Dis Markers | 2022 | 36164372 | PubTator, text mining | PubMed |
| The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting. | Cell Death Discov | 2022 | 36163119 | PubTator, text mining | PubMed |
| Bioinformatic analysis and experimental validation identified DNA methylation-Related biomarkers and immune-cell infiltration of atherosclerosis. | Front Genet | 2022 | 36159969 | PubTator, text mining | PubMed |
| The role of miR-200 family in the regulation of hallmarks of cancer. | Front Oncol | 2022 | 36158660 | PubTator, text mining | PubMed |
| Transcriptional regulation of INK4/ARF locus by cis and trans mechanisms. | Front Cell Dev Biol | 2022 | 36158211 | PubTator, text mining | PubMed |
| Super enhancers: Pathogenic roles and potential therapeutic targets for acute myeloid leukemia (AML). | Genes Dis | 2022 | 36157504 | PubTator, text mining | PubMed |
| Single-cell gene regulation network inference by large-scale data integration. | Nucleic Acids Res | 2022 | 36155797 | PubTator, text mining | PubMed |
| Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer. | Clin Epigenetics | 2022 | 36153611 | PubTator, text mining | PubMed |
| Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1. | Leukemia | 2022 | 36151141 | PubTator, text mining | PubMed |
| Identification of Differentially Expressed Genes and Prediction of Expression Regulation Networks in Dysfunctional Endothelium. | Genes (Basel) | 2022 | 36140731 | PubTator, text mining | PubMed |
| Benefits from Adjuvant Chemotherapy in Patients with Resected Non-Small Cell Lung Cancer: Possibility of Stratification by Gene Amplification of ACTN4 According to Evaluation of Metastatic Ability. | Cancers (Basel) | 2022 | 36139525 | PubTator, text mining | PubMed |
| Bioinformatic Analyses of Broad H3K79me2 Domains in Different Leukemia Cell Line Data Sets. | Cells | 2022 | 36139405 | PubTator, text mining | PubMed |
| Polycomb Directed Cell Fate Decisions in Development and Cancer. | Epigenomes | 2022 | 36135315 | PubTator, text mining | PubMed |
| In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma. | Curr Oncol | 2022 | 36135086 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=35